Titre:
  • Exquisite antitumour response to trastuzumab in a patient with no evidence of Ras-Raf-MAPK and PI3K-Akt pathways activation.
Auteur:Mano, Max S.; Awada, Ahmad; Minisini, A; Durbecq, Virginie; Di Leo, Angelo; Piccart-Gebhart, Martine
Informations sur la publication:Breast, 13, 4, page (347-349)
Statut de publication:Publié, 2004-08
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Breast cancer
Epithelial growth factor
Raf kinase inhibitors
Survival pathways
Trastuzumab
MeSH keywords:1-Phosphatidylinositol 3-Kinase
Antibodies, Monoclonal -- therapeutic use
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- genetics
Breast Neoplasms -- immunology
Drug Resistance, Neoplasm
Female
Genes, ras
Humans
Middle Aged
Mitogen-Activated Protein Kinase Kinases
Receptor, erbB-2 -- genetics
Treatment Outcome
raf Kinases
Note générale:Case Reports
Journal Article
Langue:Anglais
Identificateurs:urn:issn:0960-9776
info:doi/10.1016/j.breast.2003.11.009
info:pii/S0960977604000153
info:scp/4444248291
info:pmid/15325672